Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is an open labeled phase II single arm trial. The patients with clinical stage II and III will undergo core-needle biopsy of breast tumor for histologic diagnosis, immunohistochemical studies for estrogen receptor (ER), progesterone receptor(PR), HER-2/neu and others. PET or ultrasound results will determine the positivity of lymph node metastasis.
Critère d'inclusion
- Breast Cancer